Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease (Marketwire via Yahoo! Finance)
The U.S. Food and Drug Administration has accepted for filing the supplemental New Drug Application for the use of Neupro (Rotigotine Transdermal System) as adjunctive therapy with levodopa in adult patients with advanced-stage Parkinson's disease